Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

ArQule Inc (NASDAQ:ARQL)

1.66
Delayed Data
As of 12:53pm ET
 -0.04 / -2.35%
Today’s Change
1.04
Today|||52-Week Range
2.50
+36.07%
Year-to-Date
No recent news for ArQule Inc.

Today’s Trading

Previous close1.70
Today’s open1.70
Day’s range1.60 - 1.75
Volume154,587
Average volume (3 months)173,530
Market cap$106.8M
Dividend yield--
Data as of 12:53pm ET, 07/30/2015

Growth & Valuation

Earnings growth (last year)+5.13%
Earnings growth (this year)+11.71%
Earnings growth (next 5 years)+5.00%
Revenue growth (last year)-29.28%
P/E ratioNM
Price/Sales6.79
Price/Book2.63

Competitors

 Today’s
change
Today’s
% change
JNPJuniper Pharmaceutic...+0.53+5.46%
GLMDGalmed Pharmaceutica...-0.20-2.03%
REPHRecro Pharma Inc-0.35-2.66%
CPIXCumberland Pharmaceu...-0.09-1.47%
Data as of 12:53pm ET, 07/30/2015

Financials

Next reporting dateAugust 4, 2015
EPS forecast (this quarter)-$0.08
Annual revenue (last year)$11.3M
Annual profit (last year)-$23.4M
Net profit margin-207.85%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chief Executive Officer &
Director
Paolo Pucci
President, COO, Secretary &
General Counsel
Peter S. Lawrence
Corporate headquarters
Woburn, Massachusetts

Forecasts